PharmGKB Blog
Wednesday, December 19, 2012

CP&T Issue Focuses on Personalized Medicine

›
The October 2012 issue of Clinical Pharmacology & Therapeutics focuses on individualized medicine including articles that discuss, revea...
Thursday, December 13, 2012

CPIC publishes guidelines on interpreting genetic test results for HLA-B*5801 when prescribing allopurinol therapy.

›
Allopurinol is an analog of the purine base hypoxanthine. It inhibits the conversion of hypoxanthine and xanthine to uric acid by XDH an...
Friday, December 7, 2012

European Medicines Agency Drug Labels

›
European Public Assessment Reports (EPARs) for drugs published by the European Medicines Agency ( EMA ) that include pgx information are now...
Monday, December 3, 2012

New PGRN Featured Project and PI for the Month of December

›
The  PGRN  website is featuring a new project and investigator of the month from the NWAP (Pharmacogenetics in Rural and Underserved Po...

PharmGKB welcomes Julia Barbarino to the team

›
We are pleased to welcome scientific curator Julia Barbarino to the PharmGKB team. Julia recently completed her master's in Medical Mole...
Wednesday, November 21, 2012

New VIP gene summary for CYP2E1

›
A new VIP summary is available for CYP2E1, a member of the cytochrome P450 family of drug metabolizing enzymes. CYP2E1 is constitutively e...
Tuesday, November 6, 2012

PharmGKB welcomes Ugur Hodoglugil to the team

›
We are pleased to welcome scientific curator Ugur Hodoglugil to the PharmGKB team. Previously, Ugur has worked as research scientist on iden...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.